BA
The Boeing Company
BA has lower modeled downside risk, despite its lower overall score.
EVLV
Evolv Technologies Holdings, Inc.
EVLV has a slight edge over BA overall, supported by stronger fundamentals and stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
EVLV Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Strong | |
| Unavailable |
EVLV's revenue and cash flow are currently healthy, but its profitability is weak. There isn't enough data to rate its balance sheet.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
EVLV PE Valuation
EVLV has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
EVLV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect EVLV's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over EVLV on earnings quality, reporting a profit while its opponent remains loss making.
EVLV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.10 | +$0.27 |
| Q2 2026 | -$0.02 | +$0.53 |
| Q1 2026 | -$0.22 | +$0.06 |
| Q4 2025 | -$0.20 | +$0.15 |
| Q3 2025 | -$0.37 | -$0.03 |
| Q2 2025 | -$0.55 | -$0.43 |
| Q1 2025 | -$0.28 | +$0.31 |
| Q4 2024 | -$0.35 | +$0.36 |
EVLV is still losing money, but far less than before: $0.10 per share over the past year, against $0.98 at its worst in mid-2023.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over EVLV on profitability, with a higher operating margin.
EVLV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $47.3M | +10% |
| Q2 2026 | $43.8M | +34% |
| Q1 2026 | $46.3M | +45% |
| Q4 2025 | $38.5M | +32% |
| Q3 2025 | $42.9M | +57% |
| Q2 2025 | $32.5M | +27% |
| Q1 2025 | $32M | +48% |
| Q4 2024 | $29.1M | +33% |
EVLV has the edge over BA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | -10 points |
| Q2 2026 | -24% | +30 points |
| Q1 2026 | -18% | +27 points |
| Q4 2025 | -21% | +44 points |
| Q3 2025 | -20% | +50 points |
| Q2 2025 | -54% | +34 points |
| Q1 2025 | -45% | +58 points |
| Q4 2024 | -65% | +36 points |
EVLV's operating margin was −30% last quarter, down 10 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over EVLV on cash flow, with more consistent year-over-year improvement.
EVLV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18M | +410% |
| Q2 2026 | $11.9M | +463% |
| Q1 2026 | -$3.2M | -$640K |
| Q4 2025 | $15.6M | +386% |
| Q3 2025 | $3.5M | -9.8% |
| Q2 2025 | $2.1M | +$24M |
| Q1 2025 | -$2.5M | +$13.5M |
| Q4 2024 | $3.2M | +$6.3M |
EVLV has burned cash in most quarters: $42M over the past year, about seven times what it generated the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
EVLV Net Leverage
EVLV's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
EVLV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.8 | Neutral |
| Stochastic | 20.9 | Neutral |
EVLV's weekly RSI is 37 (neutral) and its Stochastic is 21 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
EVLV PE vs Industrials Sector
EVLV has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
EVLV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.51 | 7.8% below |
| 20 week MA | $5.11 | 19% below |
| 50 week MA | $5.73 | 27% below |
| 100 week MA | $5.62 | 26% below |
| 200 week MA | $4.86 | 14% below |
EVLV is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over EVLV on returns for 2026, with the stronger performance.
EVLV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.78 | $10.1 | +3.1% |
| 2021 | $10.1 | $5.04 | -50% |
| 2022 | $5.04 | $2.20 | -56% |
| 2023 | $2.20 | $4.72 | +115% |
| 2024 | $4.72 | $3.97 | -16% |
| 2025 | $3.97 | $6.66 | +68% |
| 2026 YTD | $6.66 | $4.16 | -38% |
EVLV's yearly returns have swung widely, from +115% in 2023 to −56% in 2022. It's down 38% so far in 2026.